Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Padagis US LLC, priced at $0.1919 per EA under NDC 00574022901. Its NADAC has been published 380 times since May 15, 2019.
FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
benazepril hydrochloride and hydrochlorothiazideStrength
20; 12.5 mg/1; mg/1
Manufacturer
Padagis US LLCNDC
00574022901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020033FDA Approved
5/19/1992
TE Code
AB
On Market Since
4/7/2019
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 380 times since May 15, 2019, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1919 per EA |
|---|---|
| All-time high | $0.7493 (Nov 13, 2019) |
| All-time low | $0.1503 (Nov 20, 2024) |
| 52-week high | $0.2705 |
| 52-week low | $0.1742 |
| Median price | $0.4689 |
| Average price | $0.4449 |
| Largest weekly change | +56.5% (Oct 18, 2023) |
| Weeks tracked | 380 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Padagis US LLC, is $0.1919 per EA (NDC 00574022901), effective Aug 19, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 63.8%. It has been tracked across 380 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since May 15, 2019, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1503 (Nov 20, 2024) to a high of $0.7493 (Nov 13, 2019), with a median of $0.4689 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 00574022901) is labeled by Padagis US LLC, and CMS classifies it as a generic product.